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Mechanism of a
Hypertensive Response to Exercise
Mottram et al. (1) recently reported in the Journal new and
unexpected findings: that a hypertensive response to exercise
(systolic blood pressure 210 mm Hg in males and 190
mm Hg in females) in normotensive and hypertensive
subjects is associated with subtle defects in systolic left
ventricular (LV) function. A number of possible mecha-
nisms were proposed.
Another explanation, not canvassed, relates to the effects
of wave reflection on the pattern of systolic LV ejection, and
on amplification of the aortic pressure wave to the site of
pressure recording in the brachial artery.
Amplification of the pressure wave to the brachial or
radial artery can be substantial during exercise, with one
study showing peak difference of 80 mm Hg between aortic
and radial peak pressure during maximal exercise (2). The
degree of amplification depends on ejection period, being
greatest when this is short, and least when it is long (3–5).
Amplification of the pulse wave is attributable to wave
reflection within the upper limb (3–6).
Most wave reflection returning to the heart comes from
the lower part of the body (trunk and lower limbs) (6). This
appears to be maintained during exercise in patients with
systolic LV dysfunction (7). However, effects of wave
reflection on the heart depend on the ability of the heart to
eject against pressure. With impaired LV contractility,
reflection has a greater effect on flow than pressure (8), and
this restricts late ejection, causing shortened ejection, with
accompanying decrease in stoke volume. The shortened
ejection in severe heart failure is responsible for absence of
systolic augmentation and appearance of the classic “di-
crotic” pulse waveform (6,9).
It is quite possible that this mechanism is responsible for
the findings of Mottram et al. (1), namely that increased
wave reflection during the challenge of exertion causes
greater reduction than usual in ejection duration, and that
this leads to greater amplification of the pulse in the upper
limb, and a greater recorded systolic pressure in the upper
limb.
Finally, such a hypothesis could be tested by measuring
ejection duration during exercise, and/or by estimating the
aortic systolic pressure from the upper limb waveform. Have
the investigators considered measuring ejection duration or
central systolic pressure?
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REPLY
We thank Dr. O’Rourke for his comments in response to
our study. Our report demonstrated that sensitive new
myocardial measurements in normotensive patients who
have a hypertensive response to exercise have abnormal left
ventricular (LV) systolic and probably also diastolic behavior
(1). We proposed that this phenomenon likely represents
intrinsic damage to the myocardium, most probably from
chronic exposure to “high-normal” levels of systemic blood
pressure, which was present in these patients (1). Clearly,
histological examination of myocardial tissue for hyperten-
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sive changes such as interstitial fibrosis would advance our
understanding of the relevant mechanisms.
Dr. O’Rourke makes the important point that systolic
pressure measured at the brachial artery is significantly
influenced by wave reflection, and that central aortic pres-
sure is a more important influence on LV systolic function.
Central aortic pressure is influenced by arterial stiffness (2),
but our preliminary findings are that, while arterial compli-
ance (measured using the pulse pressure method using radial
artery tonometry) was less in patients with a hypertensive
response to exercise compared with controls (3), it was not
related to indices of LV systolic function. Moreover, work
in progress suggests that augmentation index using carotid
tonometry is no different in those with a hypertensive
response to exercise and control subjects. Thus, although we
agree with Dr. O’Rourke that measurement of LV ejection
duration or estimation of aortic systolic pressure during
exercise may provide insight into the mechanism of a
hypertensive response to exercise as recorded with cuff blood
pressure at the upper limb, our preliminary data do not
support a major association of LV systolic dysfunction with
central hemodynamics.
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Brain Natriuretic Peptide as a
Predictor of Sudden Cardiac Death
in Patients With Myocardial Infarction
We read with interest the study by Tapanainen et al. (1).
The researchers introduced the brain natriuretic peptide
(BNP) as a good predictor of sudden cardiac death
(SCD) after acute myocardial infarction (AMI). In their
study, BNP level of the patients with AMI was used to
predict SCD. The incidence of SCD after the mean
follow-up of 43  13 months was 3.1%. The mean BNP
level in patients with SCD was 54.4  76.1 pmol/l and
it was 26.1  28.0 pmol/l in survivors. They found that
a BNP level of 23.0 pmol/l was the best cut-off point to
predict SCD. In another new study by Wang et al. (2),
higher BNP was also associated with increased risk of
overall death. The investigators reported a 27% increase
in the risk of death with each increment of 1 SD in log
of BNP level.
We know from the Multicenter Automatic Defibrillator
Implantation Trial II (MADIT II) investigators that the
survival of postmyocardial infarction patients with ejection
fraction (EF)30% will improve with prophylactic implan-
tation of a defibrillator (3). It means that irrespective of
BNP level, post-AMI patients with low EF will derive
benefit from defibrillator implantation. Approximately one-
third of the patients with prior infarction, left ventricular EF
40%, and spontaneous nonsustained ventricular tachycar-
dia (VT) have inducible sustained VT, predicting 6% to 9%
per year risk of sustained VT or SCD. A defibrillator
reduces this risk to 3% to 5% per year (3,4). An EF between
30% to 40% is a gray area for defibrillator implantation, and
this is the area that needs more clarification.
The studies have shown that BNP can probably be a good
predictor of death, especially SCD, after MI. If we know the
value of this predictive role in post-myocardial infarction
patients with EF between 30% and 40%, we may be able to
use it as a guide to defibrillator implantation decision. In the
study by Tapanainen et al. (1) the mean EF of patients with
SCD was 39.9  10.8%. It seems that most of the patients
in the study had an EF 30%, but separate analyses for
different EF levels were not shown. We believe that if the
researchers could perform a separate analysis for the patients
with EF between 30% and 40%, the role of BNP level in
predicting SCD in non-MADIT II patients might be more
clearly established.
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